West Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide

Published: Oct 11, 2018

 

EXTON, Pa.,  /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award. The honor was presented to West on October 9, 2018, at the CPhI Worldwide conference in Madrid, Spain.

(PRNewsfoto/West Pharmaceutical Services, I)

Organized by CPhI Worldwide, one of the world's largest pharma trade shows, the CPhI Pharma Awards recognize innovative pharmaceutical companies who are committed to driving the industry forward. The Excellence in Pharma: Corporate Social Responsibility Award highlights innovation in improving transparency and public outreach, while also recognizing new programs in charitable work; sustainability and environmental protection; employee reward, fair pay and ethical working policies; and training programs.  

"The CPhI Excellence in Pharma Awards are among the most prestigious awards within the pharmaceutical industry," said Steve Walton, West's Vice President, HSE & Sustainability. "It is an honor to be recognized by CPhI Worldwide, which underscores our commitment to caring for our environment, which has long been a defining characteristic of West. We strive to be stewards of a sustainable future by factoring environmental considerations into our decision making, from the raw materials we use, to our manufacturing techniques and all the way through to our packaging and distribution methods. We are proud of the progress we have made and are committed to making an even bigger impact in the future."

West has six key areas of Corporate Responsibility focus – Compliance and Ethics, Philanthropy, Diversity, Health and Safety, Environmental Sustainability and Quality. In 2017, the Company surpassed its 2020 goals for both emissions and water reduction; achieved an all-time low for employee workplace safety incidents; and continued its long-time philanthropic activities. In 2017, Corporate and Foundation giving reached over $1.8 million, and team member giving totaled nearly $530,000. Since the inception of the Company's primary philanthropic organization in 2004, West without Borders, West employees have raised and donated millions of dollars for a variety of charities located around the globe through this and other programs.

For more information about West and our commitment to Corporate Responsibility, please visit us online at www.westpharma.com.

For more information about the CPhI Pharma Awards, please visit https://awards.cphi.com.

About West
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2017 net sales of $1.6 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.

West and the diamond logo are registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.

West without Borders is not affiliated with Doctors Without Borders®, which is a registered service mark of Bureau International de Médecins San Frontières. 

Media Contact:
Eric Haman
Director, Global Corporate Communications
+1-610-594-3440
Eric.Haman@westpharma.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/west-receives-excellence-in-pharma-corporate-social-responsibility-award-at-cphi-worldwide-300729021.html

SOURCE West Pharmaceutical Services, Inc.

 
 
Company Codes: NYSE:WST
 

Back to news